Hosted on MSN2mon
Kidney disease drug developer Maze files for $100M IPOWhile the company didn't disclose terms in its SEC filing, it indicated in a filing fee schedule that it was looking to raise around $100M, a number that is like a placeholder and subject to change.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results